SCHEMBL23327849

SCHEMBL23327849

Brc1cccc(-c2cccc(-c3nc(-c4ccc(-c5ccccc5)cc4)c4sc5ccccc5c4n3)c2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 1/20 0.41
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ LIMK1 P53667 2/20 0.37
▸ ABCG2 Q9UNQ0 4/20 0.36
▸ ABCB1 P08183 2/20 0.36
▸ PIM1 P11309 1/20 0.35
▸ PIM3 Q86V86 1/20 0.35
▸ PIM2 Q9P1W9 1/20 0.35
▸ TNKS O95271 1/20 0.35
▸ TNKS2 Q9H2K2 1/20 0.35
▸ MAOA P21397 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31683825 0.98 EGFR (0.41) EGFRMEN1KMT2ANPC1ALDH1A1
SCHEMBL23327840 0.98 EGFR (0.42) EGFRMEN1KMT2ANPC1ALDH1A1
SCHEMBL17565579 0.95 EGFR (0.44) EGFRMEN1KMT2ANPC1ALDH1A1
SCHEMBL31683838 0.94 LIMK1 (0.38) EGFRMEN1KMT2ANPC1ALDH1A1
SCHEMBL18158883 0.93 EGFR (0.42) EGFRMEN1KMT2ANPC1ALDH1A1
SCHEMBL16901971 0.93 LIMK1 (0.41) MEN1KMT2AMAPTLIMK1PIM1
SCHEMBL16902269 0.93 LIMK1 (0.41) MEN1KMT2AMAPTLIMK1PIM1
SCHEMBL18017957 0.93 LIMK1 (0.41) MEN1KMT2AMAPTLIMK1PIM1
SCHEMBL18370232 0.93 LIMK1 (0.41) MEN1KMT2AMAPTLIMK1PIM1
SCHEMBL18017788 0.93 LIMK1 (0.41) MEN1KMT2AMAPTLIMK1PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12415949-B2 Compound, organic electroluminescent device, and display device SK INC. (KR) 2025-09-16 — — US disclosed
US-20210143337-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND DISPLAY DEVICE SK MATERIALS CO., LTD. (KR) 2021-05-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12415949-B2 Compound, organic electroluminescent device, and display device L1CAM, EML4, OCIAD2 EGFR 3481/4885MEN1 2723/4885KMT2A 2958/4885
US-20210143337-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND DISPLAY DEVICE L1CAM, EML4, OCIAD2 EGFR 3481/4885MEN1 2723/4885KMT2A 2958/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback